Sudeep Pharma IPO Fully Subscribed on Day 1
Sudeep Pharma's IPO concludes November 25 after strong第一天 response. Grey market premium hits ₹121, signaling 20% listing gains. Key dates and subscription details revealed.
Category : Search result: MSME pharma
India's 4 Labour Codes: Historic Economic Reform
India's four labour codes consolidate 29 laws, promising worker security, enterprise agility and investor confidence. Learn how this historic reform will boost economic growth.
Aurobindo Pharma China Facility Targets Break-Even by FY26
Aurobindo Pharma's China facility currently faces $1M loss but aims for break-even by Q3-Q4 FY26. CFO outlines growth drivers including Pen-G ramp-up and biosimilar commercialization.
Karnataka Health Minister's Directive to Pharma Industry
Karnataka Health Minister Dinesh Gundu Rao urges the pharma sector to adhere to regulations, highlighting critical public health and industry credibility issues.
Labour Codes Transform MSME Compliance Landscape
India's new Labour Codes ease compliance for MSMEs while expanding worker benefits. Industry experts debate cost impacts versus long-term formalization gains. Implementation expected by April 2026.
Eli Lilly First Pharma to Reach $1 Trillion Market Cap
Eli Lilly makes pharmaceutical history as first company to achieve $1 trillion market capitalization after shares rose 1.7% on November 21, 2025. Learn what this means for investors.
Muthoot Fincorp Spark Awards Celebrates Small Businesses
Muthoot Fincorp honored 20 outstanding small business owners at the grand premiere of Spark Awards in Delhi. Celebrating entrepreneurship and innovation across India.
QCO Withdrawal Eases MSME Costs, Opens Door to Chinese Imports
India's withdrawal of Quality Control Orders brings cost relief to MSMEs but raises concerns about cheap Chinese imports flooding the market. GTRI warns of trade implications.
Smallcap Pharma Stock Gains 10% Despite Market Sell-Off
A smallcap pharma stock listed on NSE defied market trends with a 10% surge on November 21, 2024. Discover the driving factors behind this remarkable performance.
IPO Market Sees ₹76,000 Crore Pipeline in Nov 2025
India's IPO market surges with ₹76,000 crore offerings. Excelsoft Technologies fully subscribed, Sudeep Pharma at 50%. Expert analysis on both IPOs and GMP trends revealed.
Sudeep Pharma IPO: ₹895 Cr Offer Opens, ₹130 Grey Market Premium
Sudeep Pharma's ₹895 crore IPO opens with ₹563-593 price band. Grey market shows ₹130 premium. Analysts recommend long-term investment for 2-5 years horizon.
Sudeep Pharma IPO: ₹895 Crore Offer Opens Today
Sudeep Pharma's ₹895 crore IPO opens today. Price band ₹563-593 per share. Learn about company details, investment minimums & global presence. Subscribe now!
Sudeep Pharma IPO: 22% GMP, Opens Nov 21
Sudeep Pharma's ₹95 crore IPO opens November 21 with strong grey market premium. Learn price band, dates, financials & investment details for this pharma ingredients maker.
BlackSoil Plans 50% Growth After Caspian Debt Merger
BlackSoil Capital accelerates MSME lending post-merger with Caspian Debt, targeting 50% growth and doubled profits while maintaining 1.5% NPAs. Read how they're transforming small business financing.
Sudeep Pharma IPO: ₹895 Cr Issue Opens Nov 21
Sudeep Pharma's ₹895 crore IPO opens November 21-25. Price band ₹563-593 per share. Company manufactures pharmaceutical excipients and speciality ingredients.
SME IPO Boom, Bust & Regulatory Reset Explained
Explore India's SME IPO journey: post-pandemic retail frenzy, 200x oversubscriptions, 50% listing gains, and Sebi's new profitability rules cooling the market. Understand the future.
Sudeep Pharma IPO: Price Band ₹563-593 Per Share
Sudeep Pharma IPO opens November 21 with price band ₹563-593 per share. Company aims to raise ₹95 crore. Learn key dates, financials, and investment details.
3 Stocks to Watch After Cabinet's Export Mission
Indian cabinet approves ₹25,060 crore export promotion mission. Discover three stocks poised to benefit from the MSME and export-focused initiative. Add these to your watchlist now.
NBFCs Slow MSME Lending Amid Rising Credit Risks
India's NBFCs including Bajaj Finance and IIFL Finance are scaling back MSME loans as bad debts rise. Learn why lenders are shifting to secured lending and tighter underwriting standards.
Remedium Lifecare Q2 Profit Jumps 92% to ₹38.62 Cr
Remedium Lifecare reports stellar Q2 results with profit nearly doubling to ₹38.62 crore. Revenue surges 22% driven by strong pharmaceutical exports and domestic growth.
India scraps 76 QCOs to boost manufacturing sector
Indian government removes quality control orders on 76 manufacturing inputs, cutting costs for MSMEs by 8-12% and enhancing global competitiveness. Key reforms span chemicals, metals, and steel sectors.
Quality Control Orders Fail Indian Industries: NITI Aayog
NITI Aayog report reveals how Quality Control Orders hurt MSME competitiveness and exports. Learn how India is overhauling standards framework to boost manufacturing.
European Pharma Stocks Rebound from AI Shift
European weight-loss drug makers surge as investors rotate capital from expensive AI stocks into healthcare. Zealand Pharma leads with a 20% weekly jump. Explore the market dynamics.
Purdue Pharma Wins Bankruptcy Approval in Opioid Case
Purdue Pharma receives court approval for $7.4 billion opioid settlement after Supreme Court intervention. Sackler family to pay $6.5 billion over 15 years in landmark case.
Purdue Pharma $7B Opioid Settlement Gets Court Nod
Federal judge approves Purdue Pharma's bankruptcy plan requiring Sackler family to pay $7 billion and surrender company ownership. Thousands of opioid victims to receive compensation in historic settlement.
Flipkart Ends Commission for Products Under ₹1,000
Flipkart removes commission fees for sellers listing products below ₹1,000, empowering MSMEs and enhancing customer affordability across India. Discover how this impacts small businesses.
Lincoln Pharma Aims for Rs 1000 Crore Revenue
Lincoln Pharmaceuticals Ltd announces ambitious plan to achieve Rs 1000 crore revenue within three years through strategic expansion and new product launches. Read more about their growth strategy.
Govt Withdraws BIS Norms on Polyester, Polymers
Centre withdraws quality control orders on polyester and petrochemical inputs, providing cost relief for MSMEs in textiles and manufacturing sectors while increasing import competition.
India shifts exports from US to Africa, Asia markets
India launches Plan B to counter US tariffs by redirecting $18B MSME exports to Ghana, Rwanda, Uganda, Nepal and other emerging markets through buyer-seller meets and strategic partnerships.
₹1,914 Cr PLI Boost for Domestic White Goods Manufacturing
India's PLI scheme for white goods gets a ₹1,914 crore investment boost from 13 companies, boosting domestic manufacturing of AC and LED components and creating jobs.
Page 2 of 4